Jerome J Dvonch's most recent trade in Sonoma Pharmaceuticals Inc. was a trade of 13,500 Restricted Stock Units done . Disclosure was reported to the exchange on June 19, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sonoma Pharmaceuticals Inc. | Jerome J. Dvonch | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2025 | 13,500 | 25,515 | - | - | Restricted Stock Units | |
| Sonoma Pharmaceuticals Inc. | Jerome J. Dvonch | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 10,000 | 15,891 | - | - | Restricted Stock Units | |
| Sonoma Pharmaceuticals Inc. | Jerome J. Dvonch | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 53,586 | 84,595 (4%) | 3% | - | Common Stock, $0.0001 par value | |
| Sonoma Pharmaceuticals Inc. | Jerome Dvonch J. | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 60,000 | 117,777 | - | - | Stock option (right to buy) | |
| Sonoma Pharmaceuticals Inc. | Jerome J. Dvonch | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 27,777 | 27,777 | - | - | Stock option (right to buy) |